Vanessa
Roldan Schilling
Catedraticos de Universidad Vinculados H.V.Arrixaca
![Foto de Mariano](/img/nophoto.png)
Mariano
Valdés Chávarri
Publicaciones en las que colabora con Mariano Valdés Chávarri (58)
2018
-
Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers
Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34
-
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials
Mayo Clinic Proceedings, Vol. 93, Núm. 8, pp. 1065-1073
-
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality
International Journal of Clinical Practice, Vol. 72, Núm. 3
-
Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients
International Journal of Cardiology, Vol. 254, pp. 125-131
-
Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality
Cardiology Journal
-
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation
European Journal of Clinical Investigation, Vol. 48, Núm. 6
-
Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED
American Heart Journal, Vol. 197, pp. 27-34
-
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol
Clinical Therapeutics, Vol. 40, Núm. 1, pp. 114-122
-
Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project
Journal of General Internal Medicine, Vol. 33, Núm. 6, pp. 847-854
2017
-
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
Thrombosis and Haemostasis, Vol. 117, Núm. 7, pp. 1448-1454
-
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
Scientific Reports, Vol. 7
-
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
Scientific Reports, Vol. 7, Núm. 1
-
Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and abc-bleeding risk scores: The murcia atrial fibrillation project
Thrombosis and Haemostasis, Vol. 117, Núm. 10, pp. 1848-1858
-
Long-term stroke risk prediction in patients with atrial fibrillation: Comparison of the ABC-stroke and CHA2DS2-VASc scores
Journal of the American Heart Association, Vol. 6, Núm. 7
-
Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation
American Journal of Cardiology, Vol. 120, Núm. 12, pp. 2176-2181
2016
-
Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular
Revista Espanola de Cardiologia Suplementos, Vol. 16, pp. 25-32
-
Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?
Circulation Journal, Vol. 80, Núm. 10, pp. 2102-2108
-
Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion
Circulation Journal, Vol. 80, Núm. 3, pp. 605-612
-
Repercusiones en la posología de los anticoagulantes orales no antagonistas de la vitamina K por las variaciones de la función renal de los pacientes con fibrilación auricular e insuficiencia cardiaca aguda reciente
Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 134-140
-
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion
International Journal of Cardiology, Vol. 217, pp. 42-48